Proposed LCD DL40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS
Policy LCD-DL40140 · Clinical Laboratory
Impact of new LCD on organ transplant testing reimbursement.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code T86.10.
Signal breakdown
8 shown · 8 total in platform
Critical
0%
High
38%
Routine
63%
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-DL40140 · Clinical Laboratory
Impact of new LCD on organ transplant testing reimbursement.
Policy LCD-L40140 · Clinical Laboratory
CGS finalizes molecular allograft rejection testing coverage for KY & OH.
Policy LCD-DL40249 · Transplantation
New LCD could impact solid organ testing reimbursements.
Policy LCD-L40249 · Clinical Laboratory
WPS finalizes molecular allograft rejection testing coverage (eff. 8/30/26)
Policy LCD-L40060 · Clinical Laboratory
Noridian finalizes molecular allograft rejection testing coverage (eff. 8/30/26)
Policy LCD-L40062 · Clinical Laboratory
Noridian finalizes coverage for molecular allograft rejection testing, eff. 8/30
Policy LCD-L40058 · Clinical Laboratory
Palmetto MolDX LCD for allograft rejection molecular testing eff. 8/30/26
Policy LCD-L38680 · Clinical Laboratory
WPS LCD L38680 for allograft rejection molecular testing now retired.
Audit documentation
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.